Ammonia N 13 Injection, USP
Showing 1 - 25 of >10,000
Ammonia N-13 Myocardial Blood Flow Absolute Quantification by
Recruiting
- Myocardial Ischemia
- +7 more
- Myocardial Perfusion Imaging Study
- AMMONIA N-13 37.5 mCi in 1 mL INTRAVENOUS INJECTION [Ammonia N 13]
-
Miami, Florida
- +3 more
Jan 4, 2023
N-13 Ammonia Safety Trial in Montréal (N-13 ammonia intravenous injection)
Recruiting
- N-13 Ammonia Safety
- N-13 ammonia intravenous injection
-
Montréal, Quebec, CanadaCentre Hospitalier de l'université de Montréal
Aug 5, 2022
Sickle Cell Disease Trial in Memphis ([13N]NH3, Lexiscan, Positron emission tomography)
Not yet recruiting
- Sickle Cell Disease
- [13N]NH3
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jan 11, 2023
Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT
Completed
- Coronary Artery Disease
- Cardiac Perfusion Rest/Stress Digital PET/CT
- +2 more
-
Stanford, CaliforniaStanford University
Oct 24, 2021
Biomarkers of Risk of Parkinson Disease
Active, not recruiting
- Parkinson Disease
- +2 more
- 6-[18F]Fluorodopamine
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
Coronary Artery Disease Trial in Saint Louis (Ga-68 Galmydar, 13N-ammonia)
Recruiting
- Coronary Artery Disease
- Ga-68 Galmydar
- 13N-ammonia
-
Saint Louis, MissouriWashington University School of Medicine
Nov 20, 2022
Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)
Recruiting
- Amyloidosis, Primary
- Cardiomyopathy
- F-18 florbetapir/C-11 acetate PET
- +2 more
-
Boston, MassachusettsBrigham and Womens' Hospital
Oct 23, 2022
Pharmacokinetics, Safety, Tolerability Trial in Overland Park (5-methoxy-N,N-dimethyltryptamine succinate salt, Placebo)
Recruiting
- Pharmacokinetics
- +2 more
- 5-methoxy-N,N-dimethyltryptamine succinate salt
- Placebo
-
Overland Park, KansasAltasciences Clinical Kansas, Inc
Jan 13, 2023
Myocardial Infarction, Coronary Microvascular Dysfunction, Vasospasm, Coronary Trial in Gwangju (Intravascular imaging (OCT),
Recruiting
- Myocardial Infarction
- +2 more
- Intravascular imaging (OCT), Invasive physiologic assessment (FFR, CFR, IMR), or Non-invasive physiologic assessment (N-13 ammonia PET)
-
Gwangju, Korea, Republic ofChonnam National University Hospital
Mar 13, 2022
Chronic Right-Sided Heart Failure, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Primary, 2 Trial in Ottawa (drug,
Recruiting
- Chronic Right-Sided Heart Failure
- +5 more
- Spironolactone
- +3 more
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Nov 19, 2021
Microvascular Coronary Artery Disease Trial in Worldwide (SAR407899, Placebo, Adenosine)
Terminated
- Microvascular Coronary Artery Disease
- SAR407899
- +5 more
-
Los Angeles, California
- +9 more
Mar 15, 2022
Coronary Disease Trial in Beijing (18F-FMPP)
Unknown status
- Coronary Disease
-
Beijing, Dongcheng, ChinaPeking union medical college hospital
Oct 21, 2020
Liver Tumor, Liver Tumors Trial in Boston (N-13 ammonia or F-18 fluorodeoxyglucose, PET scan)
Completed
- Liver Tumor
- Liver Neoplasms
- N-13 ammonia or F-18 fluorodeoxyglucose
- PET scan
-
Boston, Massachusetts
- +1 more
Mar 4, 2020
Refralon®, Concentrate for Solution for Intravenous Injection in
Recruiting
- Paroxysmal Atrial Fibrillation
- +2 more
-
Ufa, Bashkortostan Republic, Russian Federation
- +31 more
Mar 6, 2023
Anticoagulant Trial (Heparin)
Not yet recruiting
- Anticoagulant
- Heparin
- (no location specified)
Mar 15, 2023
Anticoagulant Trial (Heparin)
Not yet recruiting
- Anticoagulant
- Heparin
- (no location specified)
Mar 15, 2023
Single Rest-Stress Imaging Protocol for Myocardial Perfusion
Recruiting
- Coronary Artery Disease
- Myocardial Ischemia
- Single-Scan Two-Injection Protocol
-
Boston, MassachusettsMassachusetts General Hospital
Nov 15, 2022
Ureter Injury Trial (Saline Injection 0.9%, Indigotindisulfonate sodium 0.8%)
Not yet recruiting
- Ureter Injury
- Saline Injection 0.9%
- Indigotindisulfonate sodium 0.8%
- (no location specified)
Oct 12, 2023
Shoulder Impingement Syndrome, Adhesive Capsulitis of Shoulder Trial in Chuncheon (Ultrasound-guided glenohumeral space
Completed
- Shoulder Impingement Syndrome
- Adhesive Capsulitis of Shoulder
- Ultrasound-guided glenohumeral space triamcinolone, lidocaine and saline injection
- Ultrasound-guided subacromial space triamcinolone, lidocaine and saline injection
-
Chuncheon, Gangwondo, Korea, Republic ofChuncheon Sacred Heart Hospital
Sep 21, 2023
Liver Failure, Acute Trial in New Delhi (L-ornithine L-Aspartate, Placebo)
Not yet recruiting
- Liver Failure, Acute
- L-ornithine L-Aspartate
- Placebo
-
New Delhi, IndiaInstitute of Liver and Biliary Sciences
Mar 9, 2023
Toxic Effect of Organophosphate and Carbamate Insecticides Trial in High Point (Atropine Sulfate Ophthalmic Solution, Atropine
Completed
- Toxic Effect of Organophosphate and Carbamate Insecticides
- Atropine Sulfate Ophthalmic Solution
- Atropine Sulphate Injection
-
High Point, North CarolinaHigh Point Clinical Trials Center
Jul 20, 2021
Ornithine Transcarbamylase Deficiency Trial (AAVLK03hOTC)
Not yet recruiting
- Ornithine Transcarbamylase Deficiency
- AAVLK03hOTC
- (no location specified)
Oct 21, 2021
Acute Coronary Syndrome Trial (index of microcirculatory resistance)
Completed
- Acute Coronary Syndrome
- index of microcirculatory resistance
- (no location specified)
Nov 17, 2019
Chronic Heart Failure With Reduced Ejection Fraction Trial in Hungary, Poland, United States (IONIS-AGT-LRx, Placebo)
Active, not recruiting
- Chronic Heart Failure With Reduced Ejection Fraction
- IONIS-AGT-LRx
- Placebo
-
Little Rock, Arkansas
- +25 more
Jul 27, 2022
Palliative Care in COVID-19: Analysis of Costs of
Not yet recruiting
- COVID-19
- Palliative Care
- Analysis of costs with patient care during hospitalization
- (no location specified)
Jun 12, 2023